Acepodia, Inc. (TPEX:6976)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Biotechnology (Startups)	427.00K	16.59M
Biotechnology (Startups) Growth	-97.43%	-
Total	427.00K	16.59M
Total Growth	-97.43%	-

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Taiwan	427.00K	16.59M
Taiwan Growth	-97.43%	-
Total	427.00K	16.59M
Total Growth	-97.43%	-

Source: S&P Global Market Intelligence.